The downregulated RKIP expression in primary TCC tumors aligns with the findings of Chatterjee et al., reinforcing the potential of RKIP-mediated treatment in reducing the metastatic potential of tumor cells. This evidence concerns the gene PEBP1 and tarsal-carpal coalition syndrome.